Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by hmmmmmmmmon Feb 02, 2023 10:42pm
195 Views
Post# 35263935

RE:RE:Baxter vs Seto and Co..

RE:RE:Baxter vs Seto and Co..Baxter "purchasing of notes" was just fronting money from the interim milestone payment. Needing to beg for that is in no way a sign of strength on Spectral's end. 

No 180 in sentiment. Management issues on DIMI trial/ loss of control of DIMI, Tigris trial enrollment numbers, and basic disclosure/ transparency. Those giant things you keep trying to say don't matter.

But you keep shilling for management and your Aberta insiders group- and I'll keep reminding you of the facts.



<< Previous
Bullboard Posts
Next >>